Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial

Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges

(2020) Ashley Chen et al.   Journal of the American Heart Association

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight

(2019) So-Ryoung Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of body mass index on the safety and effectiveness of direct oral anticoagulants: a retrospective review

(2019) Jared Netley et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data

(2019) Margarita Kushnir et al.   Lancet Haematology

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

(2019) Stefan H. Hohnloser et al.   CIRCULATION

Efficacy and Safety of Edoxaban Compared to Warfarin According to the Burden of Diseases in Patients with Atrial Fibrillation: Insights from the ENGAGE AF-TIMI 48

(2019) André M Nicolau et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial

(2018) Ophelia Q. P. Yin et al.   CIRCULATION

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

(2018) Bianca Rocca et al.   EUROPEAN HEART JOURNAL

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

(2018) Jan Steffel et al.   EUROPEAN HEART JOURNAL

Use of the SAMe-TT 2 R 2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review

(2018) Hanis Zulkifly et al.   HEART RHYTHM

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

(2018) Giuseppe Boriani et al.   EUROPEAN HEART JOURNAL

North American Thrombosis Forum, AF Action Initiative Consensus Document

(2016) Christian T. Ruff et al.   AMERICAN JOURNAL OF MEDICINE

Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling

(2016) Jan Steffel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

(2016) K. Martin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

(2015) Giuseppe Boriani et al.   EUROPACE

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

(2015) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

(2010) Christian T. Ruff et al.   AMERICAN HEART JOURNAL